COVID-19 IMMUNOLOGIC PLANT-BASED MANUFACTURING

Projektträger – zwischengeschaltetes Finanzinstitut

CAPE BIO PHARMS (PTY) LTD

Ort

• Mauritius

Beschreibung

The project aims to establish a new plant-based current Good Manufacturing Practice (cGMP)-level manufacturing facility together with related processing laboratories and climate-controlled hydroponic grow rooms to produce reagents for the testing and treatment of COVID-19 and other endemic African diseases (e.g. Ebola, dengue, measles, HIV or yellow fever) in Mauritius. The facility is expected to reach a production capacity equivalent to 100 million test kits and/or vaccines per month.

Ziele

The project objective is to finance the establishment of a new state-of-the-art plant-based cGMP manufacturing facility in Mauritius to increase the production of reagents for research and diagnostic applications, vaccines, therapeutics or biosimilar development against COVID-19 and other endemic African diseases (e.g. Ebola, dengue, measles, HIV or yellow fever). The EIB's financing will follow a grant provided by FINDx to the company for the first ramp-up phase of their manufacturing activities. This innovative project intends to support substantial research and product development into areas of high, unmet medical needs by providing reagents to a plethora of diagnostic companies in the field of infectious diseases. The operation supports the control of the spread of COVID-19 as it will increase the supply of COVID-19 specific antigens and antibodies for rapid diagnostic test kits to detect whether the individual is infected with COVID-19, as well as if the individual was infected with the virus, providing critical data to determine how COVID-19 is spreading amongst communities.

Sektor(en)

• Industrie - Verarbeitendes Gewerbe/Herstellung von Waren

Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

EUR 33 million

Gesamtkosten (voraussichtlicher Betrag)

EUR 48 million

Umweltaspekte

The project will be subject to a full Environmental and Social impact Assessment and appropriate measures will be taken to avoid, reduce, mitigate, compensate and remedy the likely impact in order to comply with applicable EIB Environmental and Social Standards.

Auftragsvergabe

The Bank will require that the Promoter ensure that implementation of the project will be done in accordance with the Bank's Guide to Procurement.

Projektstatus

Unterzeichnet - 18/12/2020